本页面由Tiger Trade Technology Pte. Ltd.提供服务

Tango Therapeutics Inc.

22.22
-1.9500-8.07%
盘后:22.230.0100+0.05%16:23 EDT
成交量:961.91万
成交额:2.16亿
市值:37.55亿
市盈率:-26.45
高:24.11
开:23.85
低:21.85
收:24.17
52周最高:34.39
52周最低:6.69
股本:1.69亿
流通股本:1.21亿
量比:2.56
换手率:7.95%
股息:- -
股息率:- -
每股收益(TTM):-0.8400
每股收益(LYR):-0.8746
净资产收益率:-21.34%
总资产收益率:-12.99%
市净率:3.67
市盈率(LYR):-25.41

数据加载中...

2025/05/19

SEC问询函

Form CORRESP - Correspondence
2025/05/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/12

重要事件披露

Form 8-K - Current report
2025/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2024/11/20

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/10/28

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities